Search

Your search keyword '"Gadano A."' showing total 17 results
Start Over Author "Gadano A." Journal gastroenterology
17 results on '"Gadano A."'

1. Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America

Author

Ferreira, Caroline Marcondes, Benedita Terrabuio, Debora R., Fernandes da Costa, Roberto M., Signorelli, Izabelle Venturini, Pinto, Caroline A., Estanes-Hernández, Alma, Manriquez, Jesús Ruiz, Gutierrez-Acevedo, María N., Martinez-Garmendia, Agustina M., Ligia Aparecida, M., Macêdo, Everton, Mantovani, Augusto, Longo, Larisse, Vilela, Eduardo Garcia, Valderrama, María G., Santos-Rondon, Michelle V.S., Cardenas, Bertha, Rentería, Jorge Garavito, Torres-Made, Lilian Montserrat, Tenorio Castillo, Laura C., Aquino Ramos, José M., de Fátima Higuera de la Tijera, María, Aires, Rodrigo S., Salinas-Gómez, Diana C., Allendes, Francisca, Schacher, Fernando C., Neto, Guilherme John, Valdivia, Raúl Castro, Pagés, Josefina, Roblero, Juan P., Fainboim, Hugo, Souza, Fernanda Fernandes, Colombato, Luis, de Mello Peres, Renata, Miranda, Larissa O., Oliveira, Jade C., Ortiz, Leyla Nazal, Simian, Daniela, Puentes, Gabriel Mezzano, de Cássia Martins Alves da Silva, Rita, Gordon, Iaarah Montalvo, Chi Cervera, Luis A., Girala Salomón, Marcos A., Cuevas, María T., Montes, Pedro, Cattaneo Buteler, Máximo J., Farias, Alberto Queiroz, Curto Vilalta, Anna, Momoyo Zitelli, Patricia, Pereira, Gustavo, Goncalves, Luciana L., Torre, Aldo, Diaz, Juan Manuel, Gadano, Adrian C., Mattos, Angelo Z., Mendes, Liliana S.C., Alvares-da-Silva, Mario R., Bittencourt, Paulo L., Benitez, Carlos, Couto, Claudia Alves, Mendizabal, Manuel, Toledo, Claudio L., Mazo, Daniel F.C., Castillo Barradas, Mauricio, Uson Raposo, Eva M., Padilla-Machaca, P. Martín, Zarela Lozano Miranda, Adelina, Malé-Velázquez, René, Castro Lyra, André, Dávalos-Moscol, Milagros B., Pérez Hernández, José L., Ximenes, Rafael O., Faria Silva, Giovanni, Beltrán-Galvis, Oscar A., González Huezo, María S., Bessone, Fernando, Rocha, Tarciso D.S., Fassio, Eduardo, Terra, Carlos, Marín, Juan I., Sierra Casas, Patricia, de la Peña-Ramirez, Carlos, Aguilar Parera, Ferran, Fernandes, Flavia, da Penha Zago-Gomes, Maria, Méndez-Guerrero, Osvely, Marciano, Sebastián, Mattos, Angelo A., Oliveira, Joao C., Guerreiro, Gabriel T.S., Codes, Liana, Arrese, Marco, Nardelli, Mateus J., Silva, Marcelo O., Palma-Fernandez, Renato, Alcantara, Camila, Sánchez Garrido, Cristina, Trebicka, Jonel, Gustot, Thierry, Fernández, Javier, Clària, Joan, Jalan, Rajiv, Angeli, Paolo, Arroyo, Vicente, Moreau, Richard, and Carrilho, Flair J.

Published
2023
Full Text
View/download PDF

2. Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide

Author

Bartoletti, Michele, Brodersen, Carlos, Bruns, Tony, de Man, Robert A., Fialla, Annette Dam, Gambino, Carmine, Gautam, Vikas, Girala, Marcos, Juanola, Adria, Kim, Jeong Han, Kim, Tae Hun, Kumar, Pramod, Lattanzi, Barbara, Lee, Tae Hee, Rinaldi Lesmana, Cosmas A., Moreau, Richard, Nath, Preetam, Navarro, Gustavo, Park, Ji-Won, Pinero, Gisela, Pyrsopoulos, Nikolaos T., Restellini, Sophie, Romero, Gustavo, Sacco, Marco, Sevá-Pereira, Tiago, Simón-Talero, Macarena, Song, Do Seon, Suk, Ki Tae, Van Vlierberghe, Hans, Yim, Sun Young, Yoon, Eileen Laurel, Zaccherini, Giacomo, Piano, Salvatore, Singh, Virendra, Caraceni, Paolo, Maiwall, Rakhi, Alessandria, Carlo, Fernandez, Javier, Soares, Elza Cotrim, Kim, Dong Joon, Kim, Sung Eun, Marino, Monica, Vorobioff, Julio, Barea, Rita de Cassia Ribeiro, Merli, Manuela, Elkrief, Laure, Vargas, Victor, Krag, Aleksander, Singh, Shivaram Prasad, Lesmana, Laurentius Adrianto, Toledo, Claudio, Marciano, Sebastian, Verhelst, Xavier, Wong, Florence, Intagliata, Nicolas, Rabinowich, Liane, Colombato, Luis, Kim, Sang Gyune, Gerbes, Alexander, Durand, Francois, Roblero, Juan Pablo, Bhamidimarri, Kalyan Ram, Boyer, Thomas D., Maevskaya, Marina, Fassio, Eduardo, Kim, Hyoung Su, Hwang, Jae Seok, Gines, Pere, Gadano, Adrian, Sarin, Shiv Kumar, and Angeli, Paolo

Published
2019
Full Text
View/download PDF

3. Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America

Author

Farias, Alberto Queiroz, primary, Curto Vilalta, Anna, additional, Momoyo Zitelli, Patricia, additional, Pereira, Gustavo, additional, Goncalves, Luciana L., additional, Torre, Aldo, additional, Diaz, Juan Manuel, additional, Gadano, Adrian C., additional, Mattos, Angelo Z., additional, Mendes, Liliana S.C., additional, Alvares-da-Silva, Mario R., additional, Bittencourt, Paulo L., additional, Benitez, Carlos, additional, Couto, Claudia Alves, additional, Mendizabal, Manuel, additional, Toledo, Claudio L., additional, Mazo, Daniel F.C., additional, Castillo Barradas, Mauricio, additional, Uson Raposo, Eva M., additional, Padilla-Machaca, P. Martín, additional, Zarela Lozano Miranda, Adelina, additional, Malé-Velázquez, René, additional, Castro Lyra, André, additional, Dávalos-Moscol, Milagros B., additional, Pérez Hernández, José L., additional, Ximenes, Rafael O., additional, Faria Silva, Giovanni, additional, Beltrán-Galvis, Oscar A., additional, González Huezo, María S., additional, Bessone, Fernando, additional, Rocha, Tarciso D.S., additional, Fassio, Eduardo, additional, Terra, Carlos, additional, Marín, Juan I., additional, Sierra Casas, Patricia, additional, de la Peña-Ramirez, Carlos, additional, Aguilar Parera, Ferran, additional, Fernandes, Flavia, additional, da Penha Zago-Gomes, Maria, additional, Méndez-Guerrero, Osvely, additional, Marciano, Sebastián, additional, Mattos, Angelo A., additional, Oliveira, Joao C., additional, Guerreiro, Gabriel T.S., additional, Codes, Liana, additional, Arrese, Marco, additional, Nardelli, Mateus J., additional, Silva, Marcelo O., additional, Palma-Fernandez, Renato, additional, Alcantara, Camila, additional, Sánchez Garrido, Cristina, additional, Trebicka, Jonel, additional, Gustot, Thierry, additional, Fernández, Javier, additional, Clària, Joan, additional, Jalan, Rajiv, additional, Angeli, Paolo, additional, Arroyo, Vicente, additional, Moreau, Richard, additional, Carrilho, Flair J., additional, Ferreira, Caroline Marcondes, additional, Benedita Terrabuio, Debora R., additional, Fernandes da Costa, Roberto M., additional, Signorelli, Izabelle Venturini, additional, Pinto, Caroline A., additional, Estanes-Hernández, Alma, additional, Manriquez, Jesús Ruiz, additional, Gutierrez-Acevedo, María N., additional, Martinez-Garmendia, Agustina M., additional, Ligia Aparecida, M., additional, Macêdo, Everton, additional, Mantovani, Augusto, additional, Longo, Larisse, additional, Vilela, Eduardo Garcia, additional, Valderrama, María G., additional, Santos-Rondon, Michelle V.S., additional, Cardenas, Bertha, additional, Rentería, Jorge Garavito, additional, Torres-Made, Lilian Montserrat, additional, Tenorio Castillo, Laura C., additional, Aquino Ramos, José M., additional, de Fátima Higuera de la Tijera, María, additional, Aires, Rodrigo S., additional, Salinas-Gómez, Diana C., additional, Allendes, Francisca, additional, Schacher, Fernando C., additional, Neto, Guilherme John, additional, Valdivia, Raúl Castro, additional, Pagés, Josefina, additional, Roblero, Juan P., additional, Fainboim, Hugo, additional, Souza, Fernanda Fernandes, additional, Colombato, Luis, additional, de Mello Peres, Renata, additional, Miranda, Larissa O., additional, Oliveira, Jade C., additional, Ortiz, Leyla Nazal, additional, Simian, Daniela, additional, Puentes, Gabriel Mezzano, additional, de Cássia Martins Alves da Silva, Rita, additional, Gordon, Iaarah Montalvo, additional, Chi Cervera, Luis A., additional, Girala Salomón, Marcos A., additional, Cuevas, María T., additional, Montes, Pedro, additional, and Cattaneo Buteler, Máximo J., additional

Published
2023
Full Text
View/download PDF

4. Su1339: SEX DIFFERENCES IN VIROLOGIC (VR), BIOCHEMICAL (BR), COMPLETE RESPONSE (CR) AND HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE AMONG PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH NUCLEOS(T)IDES (NUC): A MULTICENTER LONGITUDINAL STUDY

Author

Chau, Angela, primary, Huang, Daniel, additional, Yeh, Ming-Lun, additional, Tsai, Pei-Chien, additional, Kim, Sung Eun, additional, Yoon, Eileen, additional, Oh, Hyunwoo, additional, Jeong, Jae Yoon, additional, Ahn, Sang Bong, additional, An, Jihyun, additional, Jeong, Soung Won, additional, Cho, Yong Kyun, additional, Kim, Hyoung Su, additional, Marciano, Sebastian, additional, Huang, Chung-Feng, additional, Trinh, Huy N., additional, Hoang, Joseph, additional, Maeda, Mayumi, additional, Dai, Chia-Yen, additional, Huang, Jee-Fu, additional, Gadano, Adrian, additional, Chuang, Wan-Long, additional, Jun, Dae Won, additional, Yu, Ming-Lung, additional, and Nguyen, Mindie H., additional

Published
2022
Full Text
View/download PDF

6. Su1339: SEX DIFFERENCES IN VIROLOGIC (VR), BIOCHEMICAL (BR), COMPLETE RESPONSE (CR) AND HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE AMONG PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH NUCLEOS(T)IDES (NUC): A MULTICENTER LONGITUDINAL STUDY

Author

Angela Chau, Daniel Huang, Ming-Lun Yeh, Pei-Chien Tsai, Sung Eun Kim, Eileen Yoon, Hyunwoo Oh, Jae Yoon Jeong, Sang Bong Ahn, Jihyun An, Soung Won Jeong, Yong Kyun Cho, Hyoung Su Kim, Sebastian Marciano, Chung-Feng Huang, Huy N. Trinh, Joseph Hoang, Mayumi Maeda, Chia-Yen Dai, Jee-Fu Huang, Adrian Gadano, Wan-Long Chuang, Dae Won Jun, Ming-Lung Yu, and Mindie H. Nguyen

Subjects
Hepatology, Gastroenterology
Published
2022

7. Mo1527 VIROLOGIC (VR), BIOCHEMICAL (BR), COMPLETE RESPONSE (CR) AND HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE AMONG MALE AND FEMALE PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH NUCLEOS(T)IDES (NUC): A REAL-B STUDY

Author

Chau, Angela, Yeh, Ming-Lun, Tsai, Pei-Chien, Huang, Daniel, Kim, Sung Eun, Trinh, Huy N., Yoon, Eileen, Oh, Hyunwoo, Jeong, Jae Yoon, Ahn, Sang Bong, An, Jihyun, Tseng, Cheng-Hao, Hsu, Yao-Chun, Jeong, Soung Won, Cho, Yong Kyun, Shim, Jae-Jun, Kim, Hyoung-Su, Ito, Takanori, Marciano, Sebastian, Kawashima, Keigo, Watanabe, Tsunemasa, Nozaki, Akito, Ishikawa, Toru, Inoue, Kaori, Eguchi, Yuichiro, Uojima, Haruki, Abe, Hiroshi, Takahashi, Hirokazu, Chuma, Makoto, Ishigami, Masatoshi, Hoang, Joseph, Maeda, Mayumi, Huang, Chung-Feng, Gadano, Adrian, Dai, Chia-Yen, Huang, Jee-Fu, Tanaka, Yasuhito, Chuang, Wan-Long, Lim, Seng Gee, Jun, Dae Won, Yu, Ming-Lung, and Nguyen, Mindie H.

Published
2023
Full Text
View/download PDF

8. Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide

Author

Piano, Salvatore, primary, Singh, Virendra, additional, Caraceni, Paolo, additional, Maiwall, Rakhi, additional, Alessandria, Carlo, additional, Fernandez, Javier, additional, Soares, Elza Cotrim, additional, Kim, Dong Joon, additional, Kim, Sung Eun, additional, Marino, Monica, additional, Vorobioff, Julio, additional, Barea, Rita de Cassia Ribeiro, additional, Merli, Manuela, additional, Elkrief, Laure, additional, Vargas, Victor, additional, Krag, Aleksander, additional, Singh, Shivaram Prasad, additional, Lesmana, Laurentius Adrianto, additional, Toledo, Claudio, additional, Marciano, Sebastian, additional, Verhelst, Xavier, additional, Wong, Florence, additional, Intagliata, Nicolas, additional, Rabinowich, Liane, additional, Colombato, Luis, additional, Kim, Sang Gyune, additional, Gerbes, Alexander, additional, Durand, Francois, additional, Roblero, Juan Pablo, additional, Bhamidimarri, Kalyan Ram, additional, Boyer, Thomas D., additional, Maevskaya, Marina, additional, Fassio, Eduardo, additional, Kim, Hyoung Su, additional, Hwang, Jae Seok, additional, Gines, Pere, additional, Gadano, Adrian, additional, Sarin, Shiv Kumar, additional, Angeli, Paolo, additional, Bartoletti, Michele, additional, Brodersen, Carlos, additional, Bruns, Tony, additional, de Man, Robert A., additional, Fialla, Annette Dam, additional, Gambino, Carmine, additional, Gautam, Vikas, additional, Girala, Marcos, additional, Juanola, Adria, additional, Kim, Jeong Han, additional, Kim, Tae Hun, additional, Kumar, Pramod, additional, Lattanzi, Barbara, additional, Lee, Tae Hee, additional, Rinaldi Lesmana, Cosmas A., additional, Moreau, Richard, additional, Nath, Preetam, additional, Navarro, Gustavo, additional, Park, Ji-Won, additional, Pinero, Gisela, additional, Pyrsopoulos, Nikolaos T., additional, Restellini, Sophie, additional, Romero, Gustavo, additional, Sacco, Marco, additional, Sevá-Pereira, Tiago, additional, Simón-Talero, Macarena, additional, Song, Do Seon, additional, Suk, Ki Tae, additional, Van Vlierberghe, Hans, additional, Yim, Sun Young, additional, Yoon, Eileen Laurel, additional, and Zaccherini, Giacomo, additional

Published
2019
Full Text
View/download PDF

9. Altered growth and lack of responsiveness to angiotensin II in aortic vascular smooth muscle cells from cirrhotic rats

Author

Concetta Trombino, Adrian Gadano, Didier Lebrec, Richard Moreau, Stéphane Cailmail, and Khalid A. Tazi

Subjects
Male, medicine.medical_specialty, Angiotensin receptor, Vascular smooth muscle, Endothelium, Cell Count, Biology, Liver Cirrhosis, Experimental, Muscle, Smooth, Vascular, Rats, Sprague-Dawley, medicine.artery, Internal medicine, Renin–angiotensin system, medicine, Animals, Aorta, Angiotensin II receptor type 1, Dose-Response Relationship, Drug, Hepatology, Cell growth, Angiotensin II, Gastroenterology, musculoskeletal system, Rats, Endocrinology, medicine.anatomical_structure, cardiovascular system, tissues
Abstract

BACKGROUND & AIMS: In cirrhosis, increased amounts of circulating hormones such as angiotensin II may induce vascular tone changes and alter vascular smooth muscle cell (VSMC) function and growth. The aim of this study was to investigate the growth of aortic VSMCs from cirrhotic rats with or without the addition of angiotensin II and to determine whether angiotensin II binding was preserved in cirrhotic VSMCs. METHODS: Cirrhosis was induced by bile duct ligation. Cell growth was studied in cultured aortic VSMCs at passage levels between 4 and 16 by determining cell number and protein synthesis. RESULTS: Proliferation rates of cirrhotic VSMCs were lower than those of control VSMCs. The addition of angiotensin II to control VSMCs caused an increase in cell proliferation and protein synthesis. This increase was not observed in cirrhotic cells. There were more angiotensin II receptors in cirrhotic than in control VSMCs, but no significant changes in affinities were found. Angiotensin II-stimulated protein synthesis was dependent on protein kinase C activity and increased intracellular Ca2+ concentrations. CONCLUSIONS: This study shows abnormalities in growth characteristics and responsiveness to angiotensin II of cultured aortic VSMCs from rats with cirrhosis. (Gastroenterology 1997 Jun;112(6):2065-72)

Published
1997

10. Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B

Author

Meghan Lovegren, William Sievert, Cyril Llamoso, Huy N. Trinh, David Wong, David Cohen, François Habersetzer, Ulus Salih Akarca, Anna S. Lok, Adrián Gadano, and Giampiero Carosi

Subjects
Adult, medicine.medical_specialty, Hepatitis B virus, Guanine, Time Factors, Combination therapy, Phosphorous Acids, Population, Organophosphonates, Pharmacology, medicine.disease_cause, Gastroenterology, Antiviral Agents, Pharmacotherapy, Hepatitis B, Chronic, Internal medicine, Drug Resistance, Viral, medicine, Humans, Hepatitis B e Antigens, education, education.field_of_study, Hepatology, business.industry, Adenine, virus diseases, Alanine Transaminase, Entecavir, Hepatitis B, Viral Load, medicine.disease, digestive system diseases, Treatment Outcome, HBeAg, DNA, Viral, Linear Models, Drug Therapy, Combination, business, Viral load, Biomarkers, medicine.drug
Abstract

Background & Aims Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are potent antiviral agents that might have additive or synergistic antiviral activity in treatment of patients with chronic hepatitis B (CHB). We compared the efficacy and safety of ETV monotherapy with those of a combination of ETV and TDF. Methods We performed a randomized, open-label, multicenter, superiority study of 379 nucleos(t)ide-naive patients with hepatitis B e antigen (HBeAg)-positive (n = 264) or HBeAg-negative (n = 115) CHB. Subjects were given ETV 0.5 mg (n = 182) or a combination of ETV 0.5 mg and TDF 300 mg (n = 197) for 100 weeks. Results At week 96, comparable proportions of patients in each study arm achieved the primary end point of a level of hepatitis B virus (HBV) DNA P = .088). Among HBeAg-positive patients, a greater proportion given combination therapy achieved levels of HBV DNA P = .046). However, this difference was observed only in patients with baseline levels of HBV DNA ≥10 8 IU/mL (79% vs 62%) and not in those with baseline levels of HBV DNA 8 IU/mL (83% in both arms). Rates of HBeAg loss and HBeAg seroconversion were comparable between groups, whereas the rate of alanine aminotransferase normalization was greater in the ETV monotherapy group. No HBV variants associated with ETV or TDF resistance were detected. Safety profiles were consistent with previous reports of ETV or TDF monotherapy. Conclusions The antiviral efficacy of ETV monotherapy is comparable to that of ETV plus TDF in a mixed population of nucleos(t)ide-naive patients with CHB (70% HBeAg positive). The combination therapy could provide an incremental benefit to HBeAg-positive patients with baseline levels of HBV DNA ≥10 8 IU/mL. Clinical trial information: ETV-110, the BE-LOW study; NCT00410072.

Published
2011

11. Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B

Author

Helena Brett-Smith, Joanna Yang, Jose D. Sollano, You Chen Chao, Richard J. Colonno, Anna S. Lok, Robert G. Gish, Robert A. de Man, Adrián Gadano, Kwang Hyub Han, Ting-Tsung Chang, Melissa Harris, Shou-Dong Lee, and Gastroenterology & Hepatology

Subjects
medicine.medical_specialty, Hepatitis B virus, Guanine, medicine.disease_cause, Gastroenterology, Antiviral Agents, law.invention, Hepatitis B, Chronic, Randomized controlled trial, SDG 3 - Good Health and Well-being, Double-Blind Method, law, Internal medicine, BDNA test, medicine, Humans, Hepatitis B e Antigens, Hepatology, Dose-Response Relationship, Drug, business.industry, Lamivudine, Alanine Transaminase, Entecavir, Hepatitis B, medicine.disease, digestive system diseases, Dose–response relationship, HBeAg, Immunology, DNA, Viral, business, medicine.drug
Abstract

Background & Aims: Entecavir demonstrated superior benefit to lamivudine at 48 weeks in nucleoside-naive patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB). We evaluated continued entecavir and lamivudine treatment through 96 weeks. Methods: 709 HBeAg-positive CHB patients were randomized to entecavir 0.5 mg (n = 354) or lamivudine 100 mg (n = 355) once daily. At week 52, protocol-defined virologic responders could continue blinded treatment for up to 96 weeks. Patients continuing in year 2 (entecavir, n = 243; lamivudine, n = 164) were assessed for serum hepatitis B virus (HBV) DNA, alanine aminotransferase (ALT) normalization, HBeAg seroconversion, and safety. Cumulative confirmed proportions of all treated patients who achieved these responses were also analyzed. Results: Among patients treated in year 2, 74% of entecavir-treated versus 37% of lamivudine-treated patients achieved HBV DNA

Published
2007

13. 469 Decline in Hepatitis B Surface Antigen Levels With Entecavir Treatment in HBeAg-Positive Nucleoside Naive Chronic Hepatitis B Patients-Results From Phase III Study ETV-022

Author

Robert G. Gish, Cyril Llamoso, Ching-Lung Lai, Adrien Gadano, Hong Tang, Robert A. de Man, Song Yu, and Ting-Tsung Chang

Subjects
HBEAG POSITIVE, medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, Entecavir, Hepatitis b surface antigen, Virology, Chronic hepatitis, Internal medicine, medicine, business, Nucleoside, medicine.drug
Published
2012

14. W1808 Regression of Fibrosis/Cirrhosis with Long-Term Entecavir Therapy in Chronic Hepatitis B (CHB) Patients with Baseline Bridging Fibrosis or Cirrhosis: Results from Studies ETV-022, -027 and -901

Author

Schiff, Eugene R., primary, Lee, Samuel S., additional, Chao, You-Chen, additional, Yoon, Seung-Kew, additional, Bessone, Fernando O., additional, Wu, Shun-Sheng, additional, Kryczka, Wieslaw, additional, Lurie, Yoav, additional, Gadano, Adrian, additional, Kitis, George, additional, Beebe, Suzanne, additional, Kreter, Bruce, additional, Xu, Dong, additional, Harris, Melissa, additional, Iloeje, Uchenna H., additional, and Tang, Hong, additional

Published
2009
Full Text
View/download PDF

15. W1808 Regression of Fibrosis/Cirrhosis with Long-Term Entecavir Therapy in Chronic Hepatitis B (CHB) Patients with Baseline Bridging Fibrosis or Cirrhosis: Results from Studies ETV-022, -027 and -901

Author

Seung Kew Yoon, Wieslaw Kryczka, Dong Xu, Melissa Harris, Shun-Sheng Wu, Suzanne Beebe, Adrián Gadano, Eugene R. Schiff, Bruce Kreter, You-Chen Chao, Fernando Bessone, Hong Tang, George Kitis, Yoav Lurie, Samuel S. Lee, and Uchenna H. Iloeje

Subjects
medicine.medical_specialty, Cirrhosis, Hepatology, business.industry, Tel aviv, Gastroenterology, Entecavir, Gastroenterology department, medicine.disease, Chronic hepatitis, Family medicine, medicine, General hospital, business, Bridging fibrosis, medicine.drug
Abstract

Baseline Bridging Fibrosis or Cirrhosis: Results from Studies ETV-022, -027 and -901 Eugene R Schiff1, Samuel S Lee2,You-Chen Chao3, SeungKew Yoon4, Fernando Bessone5, Shun-Sheng Wu6, Wieslaw Kryczka7, Yoav Lurie8, Adrian Gadano9, George Kitis10, Suzanne Beebe11, Bruce Kreter12, Dong Xu11, Melissa Harris13, Hong Tang13, Uchenna Iloeje11 1University of Miami Hospital & Clinics, Miami, FL, USA; 2Liver Unit, University of Calgary, Calgary, AB, Canada; 3Tri-Service General Hospital, Taipei, Taiwan; 4Department of Internal Medicine, Kangnam St Mary’s Hospital, Seoul, Korea; 5Rosario, Santa Fe, Argentina; 6Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan; 7Wojewodzki Szpital Zespolony, Kielce, Poland; 8Department of Gastroenterology, Tel Aviv Medical Center, Tel Aviv, Israel; 9Hospital Italiano Regional Del Sur, Buenos Aires, Argentina; 10George Papanikolaou Hospital, Gastroenterology Department, Thessaloniki, Greece; 11Research & Development, Bristol-Myers Squibb Company, Wallingford, CT, USA; 12Research & Development, Bristol-Myers Squibb Company, Princeton, NJ, USA; 13Research & Development, Bristol-Myers Squibb Company, Plainsboro, NJ, USA

Published
2009

16. Entecavir Therapy for up to 96 Weeks in Patients With HBeAg-Positive Chronic Hepatitis B

Author

Gish, Robert G., primary, Lok, Anna S., additional, Chang, Ting–Tsung, additional, de Man, Robert A., additional, Gadano, Adrian, additional, Sollano, José, additional, Han, Kwang–Hyub, additional, Chao, You–Chen, additional, Lee, Shou–Dong, additional, Harris, Melissa, additional, Yang, Joanna, additional, Colonno, Richard, additional, and Brett–Smith, Helena, additional

Published
2007
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results